
First-Principles Chemical Requirement Envelope Formulation & Challenger Falsification
“Given what chemistry knows about reversible covalent warheads and nucleophilic thiolate addition, what chemically defensible latent electrophile scaffolds can achieve selective, context-dependent covalent labeling of catalytic cysteine residues without off-target plasma protein alkylation?”
CRE formulated an ab initio Chemical Requirement Envelope for targeting protease catalytic triads without systemic alkylation. By balancing the electrophilic reactivity window against the physiological pKa difference between catalytic thiolate (pKa < 6.5) and surface cysteines (pKa > 8.2), CRE mapped 2 divergent possibility branches. Branch 001 (alpha,beta-unsaturated cyanoacrylamide) survived first-principles scrutiny and RDKit conformational analysis. Branch 002 (unhindered alpha-bromoacetamide) was aggressively falsified and eliminated by Challenger review due to uncontrollable glutathione depletion.
Active-site catalytic cysteine exhibits depressed pKa (5.5–6.2) due to His-imidazolium ion pairing, providing a ~100-fold nucleophilicity advantage over neutral surface cysteines (pKa > 8.0).
PROPRIETARY X-LABS SCIENTIFIC REASONING — WITHHELD FROM EXECUTIVE SAMPLE. Exact chemical kinetics and force-field parameters available under Controlled Disclosure.
Unhindered direct SN2 alkylators exceed safe glutathione reactivity limits (> 10^3 M^-1 s^-1) and are eliminated on first principles (Baell & Walters, Nature 2014).
Request Controlled Study Access to review unredacted chemical requirement envelopes and computational parameters.